J vs TRAW · P/E 36, $14.40B cap vs rev $226.0K
Jacobs Solutions Inc. (J) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
J does not have a complete income-statement cache yet.
Latest reported TRAW revenue for 2024-12-31 was $226.0K. Net income was -$166.5M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. TRAW currently screens at market cap $12.1M.
J currently screens at market cap $14.40B and trailing P/E 36.0. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the J and TRAW stock pages for the full models.
Not investment advice.